Helix Biomedix
$15.6
3
-$0-0% Wednesday 20:00
统计数据
当日最高
15.6
当日最低
15.6
52周最高
23.5
52周最低
15.6
成交量
230
平均成交量
9
市值
4.07M
市盈率
-
股息收益率
-
股息
-
收益
30Sep预期
预期每股收益
0
实际每股收益
-4.7376
人们还关注
此列表基于关注HXBM的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
Regeneron Pharmaceuticals
REGN
市值130.59B
AMGEN
AMGN
市值179.38B
Vertex Pharmaceuticals
VRTX
市值127.99B
Biogen
BIIB
市值29.83B
Gilead Sciences
GILD
市值98.35B
Incyte
INCY
市值12.65B
Exelixis
EXEL
市值7.43B
Biomarin Pharmaceutical
BMRN
市值17.36B
关于
Biotechnology
Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.
Show more...
首席执行官
员工
8
国家
US
ISIN
US4232875074